Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision making

Cathalijne C B Post,Jan Willem M Mens,Marie A D Haverkort,Friederike Koppe,Ina M Jürgenliemk-Schulz,An Snyers,Ellen M A Roeloffzen, Eva E Schaake,Annerie Slot,Tanja C Stam,Jannet C Beukema,Hetty A van den Berg,Ludy C H W Lutgens,Hans W Nijman,Cornelis D de Kroon,Judith R Kroep,Anne M Stiggelbout,Carien L Creutzberg

Gynecologic Oncology（2021）

引用 2|浏览14

暂无评分

摘要

•Desired benefit to choose adjuvant chemotherapy was assessed in endometrial cancer.•Desired benefit varied considerably among and between patients and clinicians.•Patients desired higher survival benefit than clinicians to choose chemoradiotherapy.•Survival benefit and long-term symptoms are most important in decision making.•Patient preferences are strongly influenced by treatment history.

查看译文

关键词

Endometrial cancer,Patient preferences,Clinician preferences,Adjuvant chemotherapy,Chemoradiotherapy,Decision-making

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要